| Systematic identification of genomic markers of drug sensitivity in cancer cells MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman, A Dastur, KW Lau, ... Nature 483 (7391), 570-575, 2012 | 2541 | 2012 |
| Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours O Delattre, J Zucman, B Plougastel, C Desmaze, T Melot, M Peter, ... Nature 359 (6391), 162-165, 1992 | 2083 | 1992 |
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer I Versteege, N Sévenet, J Lange, MF Rousseau-Merck, P Ambros, ... Nature 394 (6689), 203-206, 1998 | 1691 | 1998 |
| Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 GA Rouleau, P Merel, M Lutchman, M Sanson, J Zucman, C Marineau, ... Nature 363 (6429), 515-521, 1993 | 1656 | 1993 |
| The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts O Delattre, J Zucman, T Melot, XS Garau, JM Zucker, GM Lenoir, ... New England Journal of Medicine 331 (5), 294-299, 1994 | 1251 | 1994 |
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1121 | 2012 |
| Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma I Janoueix-Lerosey, D Lequin, L Brugières, A Ribeiro, L De Pontual, ... Nature 455 (7215), 967-970, 2008 | 1034 | 2008 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 959 | 2012 |
| Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data V Boeva, T Popova, K Bleakley, P Chiche, J Cappo, G Schleiermacher, ... Bioinformatics 28 (3), 423-425, 2012 | 914 | 2012 |
| Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome YJ Cho, A Tsherniak, P Tamayo, S Santagata, A Ligon, H Greulich, ... Journal of clinical oncology 29 (11), 1424, 2011 | 826 | 2011 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ... Cancer cell 25 (3), 393-405, 2014 | 807 | 2014 |
| Ewing sarcoma: current management and future approaches through collaboration N Gaspar, DS Hawkins, U Dirksen, IJ Lewis, S Ferrari, MC Le Deley, ... J Clin Oncol 33 (27), 3036-3046, 2015 | 690 | 2015 |
| Ewing sarcoma 11; 22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. WA May, ML Gishizky, SL Lessnick, LB Lunsford, BC Lewis, O Delattre, ... Proceedings of the National Academy of Sciences 90 (12), 5752-5756, 1993 | 681 | 1993 |
| Protein interaction mapping: a Drosophila case study E Formstecher, S Aresta, V Collura, A Hamburger, A Meil, A Trehin, ... Genome research 15 (3), 376-384, 2005 | 667 | 2005 |
| Ewing sarcoma TGP Grünewald, F Cidre-Aranaz, D Surdez, EM Tomazou, E de Álava, ... Nature reviews Disease primers 4 (1), 5, 2018 | 645 | 2018 |
| Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation T Popova, E Manié, G Rieunier, V Caux-Moncoutier, C Tirapo, T Dubois, ... Cancer research 72 (21), 5454-5462, 2012 | 633 | 2012 |
| Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas MH Ruttledge, J Sarrazin, S Rangaratnam, CM Phelan, E Twist, P Merel, ... Nature genetics 6 (2), 180-184, 1994 | 611 | 1994 |
| Mesenchymal stem cell features of Ewing tumors F Tirode, K Laud-Duval, A Prieur, B Delorme, P Charbord, O Delattre Cancer cell 11 (5), 421-429, 2007 | 599 | 2007 |
| EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts J Zucman, O Delattre, C Desmaze, AL Epstein, G Stenman, F Speleman, ... Nature genetics 4 (4), 341-345, 1993 | 567 | 1993 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 537 | 2015 |
